CASC
NVO

Coppell Advisory Solutions Corp’s Novo Nordisk NVO Stock Holding History

Coppell Advisory Solutions Corp’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.55M Buy
+19,841
New +$2.36M 0.48% 48
2023
Q1 		$1.48M Sell
18,722
-4,902
-21% -$348K 0.48% 52
2022
Q4 		$1.6M Buy
+23,624
New +$1.39M 0.54% 45

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Coppell Advisory Solutions Corp's NVO Position: Q1 2024 in Review

Coppell Advisory Solutions Corp opened a new position in Novo Nordisk (NVO) in Q1 2024: 19,841 shares worth $2.55M. The stake represents 0.48% of the portfolio and ranks #48 among its holdings. This is a return to the name: Coppell Advisory Solutions Corp previously reported a position in NVO as recently as Q1 2023.

Coppell Advisory Solutions Corp first reported a position in NVO in Q4 2022 and has held it in 3 quarters since. 1,744 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • Coppell Advisory Solutions Corp held 19,841 shares of Novo Nordisk worth $2.55M as of Q1 2024.
  • Novo Nordisk was a new Coppell Advisory Solutions Corp position in Q1 2024.
  • Novo Nordisk made up 0.48% of Coppell Advisory Solutions Corp's portfolio in Q1 2024, its #48 holding.
  • Coppell Advisory Solutions Corp first reported a position in Novo Nordisk in Q4 2022 and has held it in 3 quarters since.
  • 1,744 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Coppell Advisory Solutions Corp's 13F filing for Q1 2024, filed 16 May 2024.